The gut microbiome-immune-antioxidant axis: Redox-driven host-microbial crosstalk as a determinant of cancer immunotherapy response
The gut microbiome, immune, and antioxidant (GIA) axis is introduced as a unifying, systems-level conceptual framework to explain treatment heterogeneity and optimize cancer immunotherapy outcomes to overcome therapeutic resistance and transition host-microbiome-immune integration from conceptual promise to clinical re...